Global Recombinant Human Growth Hormone Market
Global Recombinant Human Growth Hormone Market

Recombinant Human Growth Hormone Comprehensive Study by Application (Growth Hormone (GH) Deficiency, Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Other), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), Host (E.coli, Mammalian Cells Cultures) Players and Region - Global Market Outlook to 2026

Recombinant Human Growth Hormone Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 240 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Recombinant Human Growth Hormone Market?

Human growth hormone is a peptide pituitary hormone of about 190 amino acids that stimulates growth, cell reproduction, and regeneration. This hormone is synthesized and secreted by cells called somatotrophs in the anterior pituitary and also regulates body composition, fluids, and sugar and fat metabolism. Human growth hormone can be used to treat growth disorders and growth hormone deficiency. Recombinant human growth hormones are made in a laboratory using recombinant technology. These hormones work by stimulating growth in the body and used to treat growth hormone deficiency and to aid in weight gain. In the past years, recombinant human growth hormone (rhGH) primarily used for stimulating the growth of growth-retarded GH deficient (GHD) children. Recently it is being used for other conditions associated with short stature, including Turner syndrome and end-stage renal disease.

The market study is being classified, by Application (Growth Hormone (GH) Deficiency, Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age and Other) and major geographies with country level break-up.

Pfizer, Inc (United States), Novo Nordisk A/S (Denmark), Eli Lilly and Company (United States), Sandoz International GmbH (Germany), Merck Group (Germany), Genentech, Inc. (United States), Ferring Pharmaceuticals (Switzerland), Teva Pharmaceutical Industries, Ltd (Israel), Ipsen (France) and AnkeBio Co. Ltd (China) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Recombinant Human Growth Hormone market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Recombinant Human Growth Hormone market by Type, Application and Region.

On the basis of geography, the market of Recombinant Human Growth Hormone has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Hormone Deficiency in Children
  • Rise in the Off-label Usage of Growth Hormone

Market Trend
  • Technological Advancements in the Medical Science

Restraints
  • Side Effects of the Recombinant Human Growth Hormone

Opportunities
  • Increased Research and Development Investment
  • Huge Investments by Major Players

Challenges
  • Stringent Government Rules and Regulations


Market Leaders and some development strategies
In December 2020, Emisphere Technologies, Inc., a drug delivery company that utilizes its proprietary technologies to develop new oral formulations of therapeutic agents, has announced the completion of the previously announced transaction whereby Novo Nordisk A/S acquired Emisphere, on a cash-free, debt-free basis.



Key Target Audience
Recombinant Human Growth Hormone Manufacturers, Distributors, Emerging Companies, Research Professionals and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Small for Gestational Age
  • Other
By Route of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy

By Host
  • E.coli
  • Mammalian Cells Cultures

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Hormone Deficiency in Children
      • 3.2.2. Rise in the Off-label Usage of Growth Hormone
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Medical Science
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Recombinant Human Growth Hormone, by Application, Route of Administration, Distribution Channel, Host and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Recombinant Human Growth Hormone (Value)
      • 5.2.1. Global Recombinant Human Growth Hormone by: Application (Value)
        • 5.2.1.1. Growth Hormone (GH) Deficiency
        • 5.2.1.2. Adult GH Deficiency
        • 5.2.1.3. Pediatric GH Deficiency
        • 5.2.1.4. Turner Syndrome
        • 5.2.1.5. Idiopathic Short Stature
        • 5.2.1.6. Prader-Willi Syndrome
        • 5.2.1.7. Small for Gestational Age
        • 5.2.1.8. Other
      • 5.2.2. Global Recombinant Human Growth Hormone by: Route of Administration (Value)
        • 5.2.2.1. Intravenous
        • 5.2.2.2. Intramuscular
        • 5.2.2.3. Subcutaneous
        • 5.2.2.4. Oral
      • 5.2.3. Global Recombinant Human Growth Hormone by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacy
        • 5.2.3.2. Retail Pharmacy
        • 5.2.3.3. Online Pharmacy
        • 5.2.3.4. Specialty Pharmacy
      • 5.2.4. Global Recombinant Human Growth Hormone by: Host (Value)
        • 5.2.4.1. E.coli
        • 5.2.4.2. Mammalian Cells Cultures
      • 5.2.5. Global Recombinant Human Growth Hormone Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Recombinant Human Growth Hormone (Volume)
      • 5.3.1. Global Recombinant Human Growth Hormone by: Application (Volume)
        • 5.3.1.1. Growth Hormone (GH) Deficiency
        • 5.3.1.2. Adult GH Deficiency
        • 5.3.1.3. Pediatric GH Deficiency
        • 5.3.1.4. Turner Syndrome
        • 5.3.1.5. Idiopathic Short Stature
        • 5.3.1.6. Prader-Willi Syndrome
        • 5.3.1.7. Small for Gestational Age
        • 5.3.1.8. Other
      • 5.3.2. Global Recombinant Human Growth Hormone by: Route of Administration (Volume)
        • 5.3.2.1. Intravenous
        • 5.3.2.2. Intramuscular
        • 5.3.2.3. Subcutaneous
        • 5.3.2.4. Oral
      • 5.3.3. Global Recombinant Human Growth Hormone by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacy
        • 5.3.3.2. Retail Pharmacy
        • 5.3.3.3. Online Pharmacy
        • 5.3.3.4. Specialty Pharmacy
      • 5.3.4. Global Recombinant Human Growth Hormone by: Host (Volume)
        • 5.3.4.1. E.coli
        • 5.3.4.2. Mammalian Cells Cultures
      • 5.3.5. Global Recombinant Human Growth Hormone Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Recombinant Human Growth Hormone (Price)
  • 6. Recombinant Human Growth Hormone: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer, Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novo Nordisk A/S (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eli Lilly and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sandoz International GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck Group (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genentech, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ferring Pharmaceuticals (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teva Pharmaceutical Industries, Ltd (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ipsen (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AnkeBio Co. Ltd (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Recombinant Human Growth Hormone Sale, by Application, Route of Administration, Distribution Channel, Host and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Recombinant Human Growth Hormone (Value)
      • 7.2.1. Global Recombinant Human Growth Hormone by: Application (Value)
        • 7.2.1.1. Growth Hormone (GH) Deficiency
        • 7.2.1.2. Adult GH Deficiency
        • 7.2.1.3. Pediatric GH Deficiency
        • 7.2.1.4. Turner Syndrome
        • 7.2.1.5. Idiopathic Short Stature
        • 7.2.1.6. Prader-Willi Syndrome
        • 7.2.1.7. Small for Gestational Age
        • 7.2.1.8. Other
      • 7.2.2. Global Recombinant Human Growth Hormone by: Route of Administration (Value)
        • 7.2.2.1. Intravenous
        • 7.2.2.2. Intramuscular
        • 7.2.2.3. Subcutaneous
        • 7.2.2.4. Oral
      • 7.2.3. Global Recombinant Human Growth Hormone by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacy
        • 7.2.3.2. Retail Pharmacy
        • 7.2.3.3. Online Pharmacy
        • 7.2.3.4. Specialty Pharmacy
      • 7.2.4. Global Recombinant Human Growth Hormone by: Host (Value)
        • 7.2.4.1. E.coli
        • 7.2.4.2. Mammalian Cells Cultures
      • 7.2.5. Global Recombinant Human Growth Hormone Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Recombinant Human Growth Hormone (Volume)
      • 7.3.1. Global Recombinant Human Growth Hormone by: Application (Volume)
        • 7.3.1.1. Growth Hormone (GH) Deficiency
        • 7.3.1.2. Adult GH Deficiency
        • 7.3.1.3. Pediatric GH Deficiency
        • 7.3.1.4. Turner Syndrome
        • 7.3.1.5. Idiopathic Short Stature
        • 7.3.1.6. Prader-Willi Syndrome
        • 7.3.1.7. Small for Gestational Age
        • 7.3.1.8. Other
      • 7.3.2. Global Recombinant Human Growth Hormone by: Route of Administration (Volume)
        • 7.3.2.1. Intravenous
        • 7.3.2.2. Intramuscular
        • 7.3.2.3. Subcutaneous
        • 7.3.2.4. Oral
      • 7.3.3. Global Recombinant Human Growth Hormone by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacy
        • 7.3.3.2. Retail Pharmacy
        • 7.3.3.3. Online Pharmacy
        • 7.3.3.4. Specialty Pharmacy
      • 7.3.4. Global Recombinant Human Growth Hormone by: Host (Volume)
        • 7.3.4.1. E.coli
        • 7.3.4.2. Mammalian Cells Cultures
      • 7.3.5. Global Recombinant Human Growth Hormone Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Recombinant Human Growth Hormone (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Recombinant Human Growth Hormone: by Application(USD Million)
  • Table 2. Recombinant Human Growth Hormone Growth Hormone (GH) Deficiency , by Region USD Million (2015-2020)
  • Table 3. Recombinant Human Growth Hormone Adult GH Deficiency , by Region USD Million (2015-2020)
  • Table 4. Recombinant Human Growth Hormone Pediatric GH Deficiency , by Region USD Million (2015-2020)
  • Table 5. Recombinant Human Growth Hormone Turner Syndrome , by Region USD Million (2015-2020)
  • Table 6. Recombinant Human Growth Hormone Idiopathic Short Stature , by Region USD Million (2015-2020)
  • Table 7. Recombinant Human Growth Hormone Prader-Willi Syndrome , by Region USD Million (2015-2020)
  • Table 8. Recombinant Human Growth Hormone Small for Gestational Age , by Region USD Million (2015-2020)
  • Table 9. Recombinant Human Growth Hormone Other , by Region USD Million (2015-2020)
  • Table 10. Recombinant Human Growth Hormone: by Route of Administration(USD Million)
  • Table 11. Recombinant Human Growth Hormone Intravenous , by Region USD Million (2015-2020)
  • Table 12. Recombinant Human Growth Hormone Intramuscular , by Region USD Million (2015-2020)
  • Table 13. Recombinant Human Growth Hormone Subcutaneous , by Region USD Million (2015-2020)
  • Table 14. Recombinant Human Growth Hormone Oral , by Region USD Million (2015-2020)
  • Table 15. Recombinant Human Growth Hormone: by Distribution Channel(USD Million)
  • Table 16. Recombinant Human Growth Hormone Hospital Pharmacy , by Region USD Million (2015-2020)
  • Table 17. Recombinant Human Growth Hormone Retail Pharmacy , by Region USD Million (2015-2020)
  • Table 18. Recombinant Human Growth Hormone Online Pharmacy , by Region USD Million (2015-2020)
  • Table 19. Recombinant Human Growth Hormone Specialty Pharmacy , by Region USD Million (2015-2020)
  • Table 20. Recombinant Human Growth Hormone: by Host(USD Million)
  • Table 21. Recombinant Human Growth Hormone E.coli , by Region USD Million (2015-2020)
  • Table 22. Recombinant Human Growth Hormone Mammalian Cells Cultures , by Region USD Million (2015-2020)
  • Table 23. South America Recombinant Human Growth Hormone, by Country USD Million (2015-2020)
  • Table 24. South America Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 25. South America Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 26. South America Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 27. South America Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 28. Brazil Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 29. Brazil Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 30. Brazil Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 31. Brazil Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 32. Argentina Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 33. Argentina Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 34. Argentina Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 35. Argentina Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 36. Rest of South America Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 37. Rest of South America Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 38. Rest of South America Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 39. Rest of South America Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 40. Asia Pacific Recombinant Human Growth Hormone, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 42. Asia Pacific Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 43. Asia Pacific Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 44. Asia Pacific Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 45. China Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 46. China Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 47. China Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 48. China Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 49. Japan Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 50. Japan Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 51. Japan Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 52. Japan Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 53. India Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 54. India Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 55. India Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 56. India Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 57. South Korea Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 58. South Korea Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 59. South Korea Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 60. South Korea Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 61. Taiwan Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 62. Taiwan Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 63. Taiwan Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 64. Taiwan Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 65. Australia Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 66. Australia Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 67. Australia Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 68. Australia Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 73. Europe Recombinant Human Growth Hormone, by Country USD Million (2015-2020)
  • Table 74. Europe Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 75. Europe Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 76. Europe Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 77. Europe Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 78. Germany Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 79. Germany Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 80. Germany Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 81. Germany Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 82. France Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 83. France Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 84. France Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 85. France Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 86. Italy Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 87. Italy Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 88. Italy Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 89. Italy Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 90. United Kingdom Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 91. United Kingdom Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 92. United Kingdom Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 93. United Kingdom Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 94. Netherlands Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 95. Netherlands Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 96. Netherlands Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 97. Netherlands Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 98. Rest of Europe Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 99. Rest of Europe Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 100. Rest of Europe Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 101. Rest of Europe Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 102. MEA Recombinant Human Growth Hormone, by Country USD Million (2015-2020)
  • Table 103. MEA Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 104. MEA Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 105. MEA Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 106. MEA Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 107. Middle East Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 108. Middle East Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 109. Middle East Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 110. Middle East Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 111. Africa Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 112. Africa Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 113. Africa Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 114. Africa Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 115. North America Recombinant Human Growth Hormone, by Country USD Million (2015-2020)
  • Table 116. North America Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 117. North America Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 118. North America Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 119. North America Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 120. United States Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 121. United States Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 122. United States Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 123. United States Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 124. Canada Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 125. Canada Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 126. Canada Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 127. Canada Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 128. Mexico Recombinant Human Growth Hormone, by Application USD Million (2015-2020)
  • Table 129. Mexico Recombinant Human Growth Hormone, by Route of Administration USD Million (2015-2020)
  • Table 130. Mexico Recombinant Human Growth Hormone, by Distribution Channel USD Million (2015-2020)
  • Table 131. Mexico Recombinant Human Growth Hormone, by Host USD Million (2015-2020)
  • Table 132. Recombinant Human Growth Hormone Sales: by Application(K Units)
  • Table 133. Recombinant Human Growth Hormone Sales Growth Hormone (GH) Deficiency , by Region K Units (2015-2020)
  • Table 134. Recombinant Human Growth Hormone Sales Adult GH Deficiency , by Region K Units (2015-2020)
  • Table 135. Recombinant Human Growth Hormone Sales Pediatric GH Deficiency , by Region K Units (2015-2020)
  • Table 136. Recombinant Human Growth Hormone Sales Turner Syndrome , by Region K Units (2015-2020)
  • Table 137. Recombinant Human Growth Hormone Sales Idiopathic Short Stature , by Region K Units (2015-2020)
  • Table 138. Recombinant Human Growth Hormone Sales Prader-Willi Syndrome , by Region K Units (2015-2020)
  • Table 139. Recombinant Human Growth Hormone Sales Small for Gestational Age , by Region K Units (2015-2020)
  • Table 140. Recombinant Human Growth Hormone Sales Other , by Region K Units (2015-2020)
  • Table 141. Recombinant Human Growth Hormone Sales: by Route of Administration(K Units)
  • Table 142. Recombinant Human Growth Hormone Sales Intravenous , by Region K Units (2015-2020)
  • Table 143. Recombinant Human Growth Hormone Sales Intramuscular , by Region K Units (2015-2020)
  • Table 144. Recombinant Human Growth Hormone Sales Subcutaneous , by Region K Units (2015-2020)
  • Table 145. Recombinant Human Growth Hormone Sales Oral , by Region K Units (2015-2020)
  • Table 146. Recombinant Human Growth Hormone Sales: by Distribution Channel(K Units)
  • Table 147. Recombinant Human Growth Hormone Sales Hospital Pharmacy , by Region K Units (2015-2020)
  • Table 148. Recombinant Human Growth Hormone Sales Retail Pharmacy , by Region K Units (2015-2020)
  • Table 149. Recombinant Human Growth Hormone Sales Online Pharmacy , by Region K Units (2015-2020)
  • Table 150. Recombinant Human Growth Hormone Sales Specialty Pharmacy , by Region K Units (2015-2020)
  • Table 151. Recombinant Human Growth Hormone Sales: by Host(K Units)
  • Table 152. Recombinant Human Growth Hormone Sales E.coli , by Region K Units (2015-2020)
  • Table 153. Recombinant Human Growth Hormone Sales Mammalian Cells Cultures , by Region K Units (2015-2020)
  • Table 154. South America Recombinant Human Growth Hormone Sales, by Country K Units (2015-2020)
  • Table 155. South America Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 156. South America Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 157. South America Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 158. South America Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 159. Brazil Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 160. Brazil Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 161. Brazil Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 162. Brazil Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 163. Argentina Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 164. Argentina Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 165. Argentina Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 166. Argentina Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 167. Rest of South America Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 168. Rest of South America Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 169. Rest of South America Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 170. Rest of South America Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 171. Asia Pacific Recombinant Human Growth Hormone Sales, by Country K Units (2015-2020)
  • Table 172. Asia Pacific Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 173. Asia Pacific Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 174. Asia Pacific Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 175. Asia Pacific Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 176. China Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 177. China Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 178. China Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 179. China Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 180. Japan Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 181. Japan Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 182. Japan Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 183. Japan Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 184. India Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 185. India Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 186. India Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 187. India Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 188. South Korea Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 189. South Korea Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 190. South Korea Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 191. South Korea Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 192. Taiwan Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 193. Taiwan Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 194. Taiwan Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 195. Taiwan Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 196. Australia Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 197. Australia Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 198. Australia Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 199. Australia Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 200. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 201. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 202. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 203. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 204. Europe Recombinant Human Growth Hormone Sales, by Country K Units (2015-2020)
  • Table 205. Europe Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 206. Europe Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 207. Europe Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 208. Europe Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 209. Germany Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 210. Germany Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 211. Germany Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 212. Germany Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 213. France Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 214. France Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 215. France Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 216. France Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 217. Italy Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 218. Italy Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 219. Italy Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 220. Italy Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 221. United Kingdom Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 222. United Kingdom Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 223. United Kingdom Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 224. United Kingdom Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 225. Netherlands Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 226. Netherlands Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 227. Netherlands Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 228. Netherlands Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 229. Rest of Europe Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 230. Rest of Europe Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 231. Rest of Europe Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 232. Rest of Europe Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 233. MEA Recombinant Human Growth Hormone Sales, by Country K Units (2015-2020)
  • Table 234. MEA Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 235. MEA Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 236. MEA Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 237. MEA Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 238. Middle East Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 239. Middle East Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 240. Middle East Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 241. Middle East Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 242. Africa Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 243. Africa Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 244. Africa Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 245. Africa Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 246. North America Recombinant Human Growth Hormone Sales, by Country K Units (2015-2020)
  • Table 247. North America Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 248. North America Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 249. North America Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 250. North America Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 251. United States Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 252. United States Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 253. United States Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 254. United States Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 255. Canada Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 256. Canada Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 257. Canada Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 258. Canada Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 259. Mexico Recombinant Human Growth Hormone Sales, by Application K Units (2015-2020)
  • Table 260. Mexico Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2015-2020)
  • Table 261. Mexico Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2015-2020)
  • Table 262. Mexico Recombinant Human Growth Hormone Sales, by Host K Units (2015-2020)
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Recombinant Human Growth Hormone: by Application(USD Million)
  • Table 274. Recombinant Human Growth Hormone Growth Hormone (GH) Deficiency , by Region USD Million (2021-2026)
  • Table 275. Recombinant Human Growth Hormone Adult GH Deficiency , by Region USD Million (2021-2026)
  • Table 276. Recombinant Human Growth Hormone Pediatric GH Deficiency , by Region USD Million (2021-2026)
  • Table 277. Recombinant Human Growth Hormone Turner Syndrome , by Region USD Million (2021-2026)
  • Table 278. Recombinant Human Growth Hormone Idiopathic Short Stature , by Region USD Million (2021-2026)
  • Table 279. Recombinant Human Growth Hormone Prader-Willi Syndrome , by Region USD Million (2021-2026)
  • Table 280. Recombinant Human Growth Hormone Small for Gestational Age , by Region USD Million (2021-2026)
  • Table 281. Recombinant Human Growth Hormone Other , by Region USD Million (2021-2026)
  • Table 282. Recombinant Human Growth Hormone: by Route of Administration(USD Million)
  • Table 283. Recombinant Human Growth Hormone Intravenous , by Region USD Million (2021-2026)
  • Table 284. Recombinant Human Growth Hormone Intramuscular , by Region USD Million (2021-2026)
  • Table 285. Recombinant Human Growth Hormone Subcutaneous , by Region USD Million (2021-2026)
  • Table 286. Recombinant Human Growth Hormone Oral , by Region USD Million (2021-2026)
  • Table 287. Recombinant Human Growth Hormone: by Distribution Channel(USD Million)
  • Table 288. Recombinant Human Growth Hormone Hospital Pharmacy , by Region USD Million (2021-2026)
  • Table 289. Recombinant Human Growth Hormone Retail Pharmacy , by Region USD Million (2021-2026)
  • Table 290. Recombinant Human Growth Hormone Online Pharmacy , by Region USD Million (2021-2026)
  • Table 291. Recombinant Human Growth Hormone Specialty Pharmacy , by Region USD Million (2021-2026)
  • Table 292. Recombinant Human Growth Hormone: by Host(USD Million)
  • Table 293. Recombinant Human Growth Hormone E.coli , by Region USD Million (2021-2026)
  • Table 294. Recombinant Human Growth Hormone Mammalian Cells Cultures , by Region USD Million (2021-2026)
  • Table 295. South America Recombinant Human Growth Hormone, by Country USD Million (2021-2026)
  • Table 296. South America Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 297. South America Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 298. South America Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 299. South America Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 300. Brazil Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 301. Brazil Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 302. Brazil Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 303. Brazil Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 304. Argentina Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 305. Argentina Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 306. Argentina Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 307. Argentina Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 308. Rest of South America Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 309. Rest of South America Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 310. Rest of South America Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 311. Rest of South America Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 312. Asia Pacific Recombinant Human Growth Hormone, by Country USD Million (2021-2026)
  • Table 313. Asia Pacific Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 314. Asia Pacific Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 315. Asia Pacific Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 316. Asia Pacific Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 317. China Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 318. China Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 319. China Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 320. China Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 321. Japan Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 322. Japan Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 323. Japan Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 324. Japan Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 325. India Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 326. India Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 327. India Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 328. India Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 329. South Korea Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 330. South Korea Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 331. South Korea Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 332. South Korea Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 333. Taiwan Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 334. Taiwan Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 335. Taiwan Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 336. Taiwan Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 337. Australia Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 338. Australia Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 339. Australia Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 340. Australia Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 341. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 342. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 343. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 344. Rest of Asia-Pacific Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 345. Europe Recombinant Human Growth Hormone, by Country USD Million (2021-2026)
  • Table 346. Europe Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 347. Europe Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 348. Europe Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 349. Europe Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 350. Germany Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 351. Germany Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 352. Germany Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 353. Germany Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 354. France Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 355. France Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 356. France Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 357. France Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 358. Italy Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 359. Italy Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 360. Italy Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 361. Italy Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 362. United Kingdom Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 363. United Kingdom Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 364. United Kingdom Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 365. United Kingdom Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 366. Netherlands Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 367. Netherlands Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 368. Netherlands Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 369. Netherlands Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 370. Rest of Europe Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 371. Rest of Europe Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 372. Rest of Europe Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 373. Rest of Europe Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 374. MEA Recombinant Human Growth Hormone, by Country USD Million (2021-2026)
  • Table 375. MEA Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 376. MEA Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 377. MEA Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 378. MEA Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 379. Middle East Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 380. Middle East Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 381. Middle East Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 382. Middle East Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 383. Africa Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 384. Africa Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 385. Africa Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 386. Africa Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 387. North America Recombinant Human Growth Hormone, by Country USD Million (2021-2026)
  • Table 388. North America Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 389. North America Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 390. North America Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 391. North America Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 392. United States Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 393. United States Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 394. United States Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 395. United States Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 396. Canada Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 397. Canada Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 398. Canada Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 399. Canada Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 400. Mexico Recombinant Human Growth Hormone, by Application USD Million (2021-2026)
  • Table 401. Mexico Recombinant Human Growth Hormone, by Route of Administration USD Million (2021-2026)
  • Table 402. Mexico Recombinant Human Growth Hormone, by Distribution Channel USD Million (2021-2026)
  • Table 403. Mexico Recombinant Human Growth Hormone, by Host USD Million (2021-2026)
  • Table 404. Recombinant Human Growth Hormone Sales: by Application(K Units)
  • Table 405. Recombinant Human Growth Hormone Sales Growth Hormone (GH) Deficiency , by Region K Units (2021-2026)
  • Table 406. Recombinant Human Growth Hormone Sales Adult GH Deficiency , by Region K Units (2021-2026)
  • Table 407. Recombinant Human Growth Hormone Sales Pediatric GH Deficiency , by Region K Units (2021-2026)
  • Table 408. Recombinant Human Growth Hormone Sales Turner Syndrome , by Region K Units (2021-2026)
  • Table 409. Recombinant Human Growth Hormone Sales Idiopathic Short Stature , by Region K Units (2021-2026)
  • Table 410. Recombinant Human Growth Hormone Sales Prader-Willi Syndrome , by Region K Units (2021-2026)
  • Table 411. Recombinant Human Growth Hormone Sales Small for Gestational Age , by Region K Units (2021-2026)
  • Table 412. Recombinant Human Growth Hormone Sales Other , by Region K Units (2021-2026)
  • Table 413. Recombinant Human Growth Hormone Sales: by Route of Administration(K Units)
  • Table 414. Recombinant Human Growth Hormone Sales Intravenous , by Region K Units (2021-2026)
  • Table 415. Recombinant Human Growth Hormone Sales Intramuscular , by Region K Units (2021-2026)
  • Table 416. Recombinant Human Growth Hormone Sales Subcutaneous , by Region K Units (2021-2026)
  • Table 417. Recombinant Human Growth Hormone Sales Oral , by Region K Units (2021-2026)
  • Table 418. Recombinant Human Growth Hormone Sales: by Distribution Channel(K Units)
  • Table 419. Recombinant Human Growth Hormone Sales Hospital Pharmacy , by Region K Units (2021-2026)
  • Table 420. Recombinant Human Growth Hormone Sales Retail Pharmacy , by Region K Units (2021-2026)
  • Table 421. Recombinant Human Growth Hormone Sales Online Pharmacy , by Region K Units (2021-2026)
  • Table 422. Recombinant Human Growth Hormone Sales Specialty Pharmacy , by Region K Units (2021-2026)
  • Table 423. Recombinant Human Growth Hormone Sales: by Host(K Units)
  • Table 424. Recombinant Human Growth Hormone Sales E.coli , by Region K Units (2021-2026)
  • Table 425. Recombinant Human Growth Hormone Sales Mammalian Cells Cultures , by Region K Units (2021-2026)
  • Table 426. South America Recombinant Human Growth Hormone Sales, by Country K Units (2021-2026)
  • Table 427. South America Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 428. South America Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 429. South America Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 430. South America Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 431. Brazil Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 432. Brazil Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 433. Brazil Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 434. Brazil Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 435. Argentina Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 436. Argentina Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 437. Argentina Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 438. Argentina Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 439. Rest of South America Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 440. Rest of South America Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 441. Rest of South America Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 442. Rest of South America Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 443. Asia Pacific Recombinant Human Growth Hormone Sales, by Country K Units (2021-2026)
  • Table 444. Asia Pacific Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 445. Asia Pacific Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 446. Asia Pacific Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 447. Asia Pacific Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 448. China Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 449. China Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 450. China Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 451. China Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 452. Japan Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 453. Japan Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 454. Japan Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 455. Japan Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 456. India Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 457. India Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 458. India Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 459. India Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 460. South Korea Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 461. South Korea Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 462. South Korea Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 463. South Korea Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 464. Taiwan Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 465. Taiwan Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 466. Taiwan Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 467. Taiwan Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 468. Australia Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 469. Australia Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 470. Australia Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 471. Australia Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 472. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 473. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 474. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 475. Rest of Asia-Pacific Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 476. Europe Recombinant Human Growth Hormone Sales, by Country K Units (2021-2026)
  • Table 477. Europe Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 478. Europe Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 479. Europe Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 480. Europe Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 481. Germany Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 482. Germany Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 483. Germany Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 484. Germany Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 485. France Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 486. France Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 487. France Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 488. France Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 489. Italy Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 490. Italy Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 491. Italy Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 492. Italy Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 493. United Kingdom Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 494. United Kingdom Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 495. United Kingdom Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 496. United Kingdom Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 497. Netherlands Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 498. Netherlands Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 499. Netherlands Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 500. Netherlands Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 501. Rest of Europe Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 502. Rest of Europe Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 503. Rest of Europe Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 504. Rest of Europe Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 505. MEA Recombinant Human Growth Hormone Sales, by Country K Units (2021-2026)
  • Table 506. MEA Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 507. MEA Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 508. MEA Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 509. MEA Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 510. Middle East Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 511. Middle East Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 512. Middle East Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 513. Middle East Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 514. Africa Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 515. Africa Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 516. Africa Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 517. Africa Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 518. North America Recombinant Human Growth Hormone Sales, by Country K Units (2021-2026)
  • Table 519. North America Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 520. North America Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 521. North America Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 522. North America Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 523. United States Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 524. United States Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 525. United States Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 526. United States Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 527. Canada Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 528. Canada Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 529. Canada Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 530. Canada Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 531. Mexico Recombinant Human Growth Hormone Sales, by Application K Units (2021-2026)
  • Table 532. Mexico Recombinant Human Growth Hormone Sales, by Route of Administration K Units (2021-2026)
  • Table 533. Mexico Recombinant Human Growth Hormone Sales, by Distribution Channel K Units (2021-2026)
  • Table 534. Mexico Recombinant Human Growth Hormone Sales, by Host K Units (2021-2026)
  • Table 535. Research Programs/Design for This Report
  • Table 536. Key Data Information from Secondary Sources
  • Table 537. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Recombinant Human Growth Hormone: by Application USD Million (2015-2020)
  • Figure 5. Global Recombinant Human Growth Hormone: by Route of Administration USD Million (2015-2020)
  • Figure 6. Global Recombinant Human Growth Hormone: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Recombinant Human Growth Hormone: by Host USD Million (2015-2020)
  • Figure 8. South America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 9. Asia Pacific Recombinant Human Growth Hormone Share (%), by Country
  • Figure 10. Europe Recombinant Human Growth Hormone Share (%), by Country
  • Figure 11. MEA Recombinant Human Growth Hormone Share (%), by Country
  • Figure 12. North America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 13. Global Recombinant Human Growth Hormone: by Application K Units (2015-2020)
  • Figure 14. Global Recombinant Human Growth Hormone: by Route of Administration K Units (2015-2020)
  • Figure 15. Global Recombinant Human Growth Hormone: by Distribution Channel K Units (2015-2020)
  • Figure 16. Global Recombinant Human Growth Hormone: by Host K Units (2015-2020)
  • Figure 17. South America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 18. Asia Pacific Recombinant Human Growth Hormone Share (%), by Country
  • Figure 19. Europe Recombinant Human Growth Hormone Share (%), by Country
  • Figure 20. MEA Recombinant Human Growth Hormone Share (%), by Country
  • Figure 21. North America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 22. Global Recombinant Human Growth Hormone share by Players 2020 (%)
  • Figure 23. Global Recombinant Human Growth Hormone share by Players (Top 3) 2020(%)
  • Figure 24. Global Recombinant Human Growth Hormone share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Pfizer, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 27. Pfizer, Inc (United States) Revenue: by Geography 2020
  • Figure 28. Novo Nordisk A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 29. Novo Nordisk A/S (Denmark) Revenue: by Geography 2020
  • Figure 30. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 31. Eli Lilly and Company (United States) Revenue: by Geography 2020
  • Figure 32. Sandoz International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Sandoz International GmbH (Germany) Revenue: by Geography 2020
  • Figure 34. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Merck Group (Germany) Revenue: by Geography 2020
  • Figure 36. Genentech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Genentech, Inc. (United States) Revenue: by Geography 2020
  • Figure 38. Ferring Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 39. Ferring Pharmaceuticals (Switzerland) Revenue: by Geography 2020
  • Figure 40. Teva Pharmaceutical Industries, Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 41. Teva Pharmaceutical Industries, Ltd (Israel) Revenue: by Geography 2020
  • Figure 42. Ipsen (France) Revenue, Net Income and Gross profit
  • Figure 43. Ipsen (France) Revenue: by Geography 2020
  • Figure 44. AnkeBio Co. Ltd (China) Revenue, Net Income and Gross profit
  • Figure 45. AnkeBio Co. Ltd (China) Revenue: by Geography 2020
  • Figure 46. Global Recombinant Human Growth Hormone: by Application USD Million (2021-2026)
  • Figure 47. Global Recombinant Human Growth Hormone: by Route of Administration USD Million (2021-2026)
  • Figure 48. Global Recombinant Human Growth Hormone: by Distribution Channel USD Million (2021-2026)
  • Figure 49. Global Recombinant Human Growth Hormone: by Host USD Million (2021-2026)
  • Figure 50. South America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 51. Asia Pacific Recombinant Human Growth Hormone Share (%), by Country
  • Figure 52. Europe Recombinant Human Growth Hormone Share (%), by Country
  • Figure 53. MEA Recombinant Human Growth Hormone Share (%), by Country
  • Figure 54. North America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 55. Global Recombinant Human Growth Hormone: by Application K Units (2021-2026)
  • Figure 56. Global Recombinant Human Growth Hormone: by Route of Administration K Units (2021-2026)
  • Figure 57. Global Recombinant Human Growth Hormone: by Distribution Channel K Units (2021-2026)
  • Figure 58. Global Recombinant Human Growth Hormone: by Host K Units (2021-2026)
  • Figure 59. South America Recombinant Human Growth Hormone Share (%), by Country
  • Figure 60. Asia Pacific Recombinant Human Growth Hormone Share (%), by Country
  • Figure 61. Europe Recombinant Human Growth Hormone Share (%), by Country
  • Figure 62. MEA Recombinant Human Growth Hormone Share (%), by Country
  • Figure 63. North America Recombinant Human Growth Hormone Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Pfizer, Inc (United States)
  • Novo Nordisk A/S (Denmark)
  • Eli Lilly and Company (United States)
  • Sandoz International GmbH (Germany)
  • Merck Group (Germany)
  • Genentech, Inc. (United States)
  • Ferring Pharmaceuticals (Switzerland)
  • Teva Pharmaceutical Industries, Ltd (Israel)
  • Ipsen (France)
  • AnkeBio Co. Ltd (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation